［1］DA Chistiakov，MC Killingsworth，VA Myasoedova，et al.CD68/macrosialin：Not just a histochemical marker［J］.Laboratory Investigation，2017，97(1)：4-13.
[2]Yang L，Zhang Y.Tumor-associated macrophages：From basic research to clinical application［J］.Journal of Hematology & Oncology，2017，10(1)：58.
[3]Huang W，Wei X，Wei Y，et al.Biology of tumor associated macrophages in diffuse large B cell lymphoma［J］.DNA and Cell Biology，2018(37)：947-952.
[4]Schultze JL，Schmieder A，Goerdt S.Macrophage activation in human diseases［J］.Seminars in Immunology，2015，27(4)：249-256.
[5]Brian R，Affara NI，Coussens LM.Differential macrophage programming in the tumor microenvironment［J］.Trends in Immunology，2012，33(3)：119-126.
[6]Xu YL，Wang QH，Qian ZZ，et al.Expression and prognostic value of regulatory T cells and M2 macrophages in disuse large B-cell lymphonm tissues［J］.Chin J Oncol，2013，35(6)：450-455.
[7]Yin Y，Huang X，Lynn KD，et al.Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation［J］.Cancer Immunology Research，2013，1(4)：256.
[8]Wang L，Zhang C，Zhang Z，et al.Specific clinical and immune features of CD68 in glioma via 1 024 samples［J］.Cancer Management and Research，2018(10)：6409-6419.
[9]ZHANG GJ，WU AX，YAN QH，et al.The expression and significance of HLA-Ⅰ，CD68 and CD3 in gastric carcinoma and lymph node［J］.Hebei Medical Journal，2010，32(9)：1049-1050.［张国建，吴爱须，闫庆辉，等.HLA-Ⅰ、CD68和CD3抗原在胃癌及周围淋巴结的表达及意义［J］.河北医药，2010，32(9)：1049-1050.］
[10]He AJ，Hu WJ，Li X，et al.The infiltration and significance of CD68+ and CD163+ macrophages in colorectal carcinoma［J］.Journal of Colorectal & Anal Surgery，2017，23(04)：440-444.
[11]Marchesi F，Cirillo M，Bianchi A，et al.High density of CD68+/CD163+ tumour-associated macrophages(M2-TAM)at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma［J］.Hematological Oncology，2015，33(2)：110-112.
[12]Wang S，Wang L，Cao NN，et al.Expression and clinical significance of B7-H3 and CD68 in esophageal squamous cell carcinoma tissues［J］.Chinese Journal of Cancer Prevention and Treatment，2015，22(9)：666-669.
[13]Shafat MS，Gnaneswaran B，Bowles KM，et al.The bone marrow microenvironment-home of the leukemic blasts［J］.Blood Reviews，2017，31(5)：277-286.
[14]Chen S，Yang X，Feng W，et al.Characterization of peritoneal leukemia-associated macrophages in Notch1-induced mouse T cell acute lymphoblastic leukemia［J］.Molecular Immunology，2017(81)：35-41.
[15]Sha-Yan C，Xiao Y，Wen-Li F，et al.Organ-specific microenvironment modifies diverse functional and phenotypic characteristics of leukemia-associated macrophages in mouse T cell acute lymphoblastic leukemia［J］.J Immunol，2015，194(6)：2919-2929.
[16]Yang X，Feng W，Wang R，et al.Repolarizing heterogeneous leukemia-associated macrophages with more M1 characteristics eliminates their pro-leukemic effects［J］.Oncoimmunology，2017，7(4)：e1412910.
[17]SONG JX，OUYANG HM，DIAN ZJ，et al.Expression of tumor-associated macrophages in patients with myelodysplastic syndrome［J］.Chongqing Medicine，2017，46(2)：228-230.［宋建新，欧阳红梅，甸自金，等.肿瘤相关巨噬细胞在骨髓增生异常综合征患者中的表达研究［J］.重庆医学，2017，46(2)：228-230.］
[18]SHA K.Relationship between apoptosis of bone marrow cells and TNF-alpha in myelodysplastic syndrome［J］.China Practical Medical，2014，9(23)：91-92.［沙琨.骨髓增生异常综合征骨髓细胞凋亡与TNF-α关系的探讨［J］.中国实用医药，2014，9(23)：91-92.］
[19]Chen L，Yuan W，Chen Z，et al.Vasoactive intestinal peptide represses activation of tumor-associated macrophages in gastric cancer via regulation of TNFα，IL-6，IL-12 and iNOS［J］.Int J Oncol，2015，47(4)：1361-1370.
[20]Tabe Y，Jin L，Iwabuchi K，et al.Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn/CXCR4 interactions in lipid rafts［J］.Leukemia，2012，26(5)：883-892.
[21]ZHAO Y，ZHAO Y.Characteristics and molecular regulation of the origin，development and differentiation of mononuclear macrophages［J］.Chin J Immunol，2014，30(1)：126-132.［赵阳，赵勇.单核-巨噬细胞起源及发育分化的特征与分子调控［J］.中国免疫学杂志，2014，30(1)：126-132.］
[22]Burger JA，Quiroga MP，Hartmann E，et al.High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation［J］.Blood，2009，113(13)：3050.
[23]SONG JX，OUYANG HM，TANG YF，et al.Expression of leukemia-associated macrophage in bone marrow of chronic myeloid leukemia patients and its clinical significance［J］.International Journal of Laboratory Medicine，2017，38(1)：4-6.［宋建新，欧阳红梅，汤一菲，等.慢性粒细胞白血病患者骨髓中白血病相关巨噬细胞的表达及意义［J］.国际检验医学杂志，2017，38(1)：4-6.］
[24]Liu LB，Lei LI，Xiao J，et al.Comparison of immunophenotype and clinical manifestations between patients with M5a and M5b of acute monocytic leukemia［J］.Journal of Experimental Hematology，2006，14(6)：1079-1082.
[25]Holness CL，Simmons DL.Molecular cloning of CD68，a human macrophage marker related to lysosomal glycoproteins［J］.Blood，1993，81(6)：1607.
[26]EA Holzwanger，Z Alam，E Hsu，et al.A case of granulocytic sarcoma or extramedullary acute myelomonocytic leukemia of the gallbladder［J］.American Journal of Case Reports，2018(19)：1262-1266.
[27]Almond LM，Charalampakis M，Ford SJ，et al.Myeloid sarcoma：Presentation，diagnosis，and treatment［J］.Clinical Lymphoma Myeloma & Leukemia，2017，17(5)：263.
[28]Magdy M,Abdel Karim N,Eldessouki L，et al.Myeloid sarcoma［J］.Oncology Research and Treatment，2019，42(4):224-229.
[29]WANG LN，ZHENG GG.Advances in macrophages in malignant diseases of the blood system［J］.Scientia Sinica(Vitae)，2017，47(12)：1264-1271.［王丽娜，郑国光.血液系统恶性疾病中巨噬细胞的研究进展［J］.中国科学：生命科学，2017，47(12)：1264-1271.］
[30]Yoshihiro K，Daisuke N，Yoichi S，et al.Clinical significance of CD163﹢ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma［J］.Cancer Science，2013，104(7)：945-951.